The ER+ breast cancers (e.g., luminal A-subtype) are predominantly p53 wild-type (p53WT) and p53 is known to negatively regulate survivin gene transcription at the molecular level (Bailey et al., 2012; Berger et al., 2013; Dumay et al., 2013). This evidence concerns the gene TP53 and breast carcinoma.